Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 4—April 2014
Research

Rotavirus Surveillance in Urban and Rural Areas of Niger, April 2010–March 2012

Anne-Laure PageComments to Author , Viviane Jusot, Abdoul-Aziz Mamaty, Lagare Adamou, Jérôme Kaplon, Pierre Pothier, Ali Djibo, Mahamane L. Manzo, Brahima Toure, Céline Langendorf, Jean-Marc Collard, and Rebecca F. Grais
Author affiliations: Epicentre, Paris, France (A.-L. Page, C. Langendorf, R.F. Grais); Epicentre, Niamey, Niger (V. Jusot, A.-A. Mamaty, B. Toure); Centre de Recherche Médicale et Sanitaire (CERMES), Niamey (L. Adamou, J.-M. Collard); University Hospital of Dijon, Dijon, France (J. Kaplon, P. Pothier); Ministry of Health, Niamey (A. Djibo, M.L. Manzo); Niamey University, Niamey (A. Djibo)

Main Article

Table 5

Weighted analysis of rotavirus genotypes identified during a 2-year surveillance study in Niamey and Maradi region, Niger, April 2010–March 2012

Genotype and G- and P-type April 2010–March 2011
April 2011–March 2012
Niamey, n = 121
Maradi region, n = 194
Niamey, n = 49
Maradi region, n = 85
No. (%) 95% CI No. (%) 95% CI No. (%) 95% CI No. (%) 95% CI
Genotype
G1P[8] 6 (4.8) 2.1–10.5 3 (1.8) 0.6–5.7 1 (1.8) 0.2–12.4 4 (3.8) 1.3–10.6
G2P[4] 30 (25.1) 18.0–33.9 137 (60.5) 51.6–68.8 0 0
G2P[6] 9 (6.2) 3.2–11.6 5 (3.7) 9.0–1.6 0 0 2 (2.7) 0.6–10.3
G6P[6] 12 (9.4) 5.4–16.1 0 1 (1.3) 0.2–9.2 0
G9P[8] 8 (5.9) 2.9–11.6 7 (5.9) 2.8–11.9 0 1 (1.3) 0.2–8.9
G12P[8] 36 (31.4) 23.4–40.5 19 (10.9) 6.6–17.5 43 (89.2) 76.3–95.5 56 (64.1) 52.4–74.4
Others* 15 (13.2) 8.0–21.0 13 (10.0) 5.4–17.8 2 (2.7) 0.6–11.4 9 (12.3) 6.1–23.3
Mixed
5 (4.0)
1.6–9.6

10 (7.1)
3.5–13.7

2 (5.1)
1.2–19.3

13 (15.8)
9.1–26.1
G-type†
G1 10 (8.1) 4.3–14.7 4 (2.7) 1.0–7.1 2 (4.8) 1.1–18.7 4 (3.7) 1.3–10.6
G2 51 (41.9) 33.2–51.1 148 (66.5) 57.5–74.4 0 6 (7.9) 3.5–16.7
G3 3 (2.7) 0.8–8.5 17 (16.0) 10.0–24.7 0 5 (6.0) 2.4–14.3
G6 13 (10.3) 6.0–17.2 1 (0.1) 0.0–1.0 2 (3.0) 0.7–12.3 0
G9 10 (7.2) 3.8–13.1 13 (11.1) 6.4–18.5 1 (2.1) 0.3–14.2 9 (10.0) 5.0–18.7
G12
36 (31.4)
23.4–40.5

20 (11.1)
6.8–17.6

46 (95.2)
85.3–98.5

71 (82.8)
72.3–89.9
P-type†
P[4] 32 (27.0) 19.7–35.9 145 (67.8) 59.1–75.4 0 0
P[6] 27 (20.1) 13.9–28.0 14 (9.7) 5.6–16.2 2 (2.2) 0.5–9.0 13 (17.6) 10.1–28.9
P[8] 63 (53.7) 44.6–62.6 38 (23.6) 16.9–31.9 47 (97.8) 91.0–99.5 72 (83.7) 72.9–90.7

*Including G1P[6] (2), G2P[8] (9), G3P[4] (5), G3P[6] (7), G3P[8] (2), G6P[8] (3), and G12P[6] (7).
†Mixed infections counted in each G- or P-type found, potentially leading to a total number greater than N.

Main Article

Page created: March 12, 2014
Page updated: March 12, 2014
Page reviewed: March 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external